Top Markets
Coin of the day
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
주식 순위 #19170
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
주가
$1.62
마지막 동기화: 2026-08-25
시가총액
$172.47M
변동 (1일)
-3.57%
변동 (1년)
446.74%
국가
US
거래 Cypherpunk Technologies Inc. (CYPH)

카테고리

Cypherpunk Technologies Inc. (CYPH)의 주식 분할 이력
Cypherpunk Technologies Inc. 주식 (심볼: CYPH)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 26, 2026에 발생했습니다.
Aug 26, 2026 이전에 매수한 CYPH 주식 1주는 현재 0주의 CYPH 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH